ArticleOncotarget2018
VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells.
Atif J Khan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it